CrushSCI.com
126.1Average days
106Median days
24Fastest days
383Longest days
1,9332025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

24 days

Targeted co-delivery of SPAG5 siRNA and a PD-L1 inhibitor using nanoliposomes enhances antitumor immunity in a murine prostate cancer model

Authors
Ruohui Huang; Bo Jiang; Gang Xu; Haidong Zhong; Jiexia XiongShow moreShow less
Affiliations
Department of Urology, First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, Jiangxi, China; First Clinical Medical College, Gannan Medical University, Ganzhou 341000, Jiangxi, ChinaShow moreShow less
Source PDF DOI Publisher page
133 days

Zederone-calycosin ameliorates psoriasis via the AMPK/SIRT1/PGC-1α pathway: insights from the Astragali Radix-Curcumae Rhizoma herb pair

Authors
Lijuan Liu; Mengge Zhang; Shuhui Pan; Qiulong Luo; Xinran Tang; Ya Zhao; Yayun Wu; Chuanjian Lu; Ronghua Dai; Ruizhi ZhaoShow moreShow less
Affiliations
State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510120, China; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510120, China; The Second Clinical Medical College, Guangzhou University of Chinese Medicine; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, Guangdong Province 510006, China; School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning Province 110016, China; Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, Guangdong Province 510006, ChinaShow moreShow less
Source PDF DOI Publisher page
24 days

HSPA12B modulates lung injury and neutrophil-related inflammatory responses in LPS-induced acute lung injury: a potential link to the PKC-PAD4 pathway

Authors
Weifang Wu; Yushan Lin; Yize Bian; Duoduo Lin; Yuhui Wei; Xutao Zhang; Junyi Liu; Hengxing Zeng; Qinyan Lv; Yuxin Zheng; Adilai Wulamu; Yu Chen; Shiyu Huang; Jie Zhou; Xiaole Chen; Qian Yang; Nanwen ZhangShow moreShow less
Affiliations
The Department of Anesthesiology, Fuzhou First General Hospital Affiliated with Fujian Medical University, Fuzhou, Fujian, 350001, China; The Third Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, 350122, China; The School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, 350122, China; Department of Pharmacy, The First Hospital of Putian City, Putian, Fujian, 351100, China; Academy of Medical Sciences, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China; Fujian Agriculture and Forestry University, Fuzhou, Fujian, 350002, China; The Department of Anesthesiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China; The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350122, China; Key Laboratory of Natural Medicine Pharmacology in Fujian Province, Fuzhou, Fujian, 350122, China; School of Pharmacy and Medical Technology, Changji Vocational and Technical College, Xinjiang, Changji, 831100, ChinaShow moreShow less
Source PDF DOI Publisher page
64 days

Tetrandrine attenuates diabetic kidney disease by suppressing the TLR4–NF-κB–NLRP3 inflammatory signaling pathway in proximal tubular cells

Authors
Yan Yan; Wenru Wang; Heng Chen; Yao Chen; Peng Liu; Chenyang Liu; Gang Wang; Renhuan Yu; Hailing ZhaoShow moreShow less
Affiliations
Department of Nephrology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, China; Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Beijing Key Lab for Immune-Mediated Inflammatory Diseases, Department of Nephrology, China-Japan Friendship Hospital, Beijing, ChinaShow moreShow less
Source PDF DOI Publisher page
71 days

Plasma-activated solutions alleviate intestinal mucosal injury induced by pathogen–host interactions by modulating redox imbalance

Authors
Yuanchang Peng; Yuyi Ma; Xueni Wang; Rulan Ma; Huan Chen; Xiaoyuan Deng; Tianhao Min; Yanglong Nan; Shiyao Tong; Tuanhe Sun; Wei Wang; Yong Zhang; Nan Hao; Xin Xie; Kun Zhu; Kang Li; Guimin Xu; Bo Zhang; Kaijie Ren; Hao ZhangShow moreShow less
Affiliations
Department of Surgical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; State Key Laboratory of Electrical Insulation and Power Equipment, School of Electrical Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Clinical Medicine and Cancer Research Center of Shaanxi Province, Xi'an, Shaanxi, 710061, ChinaShow moreShow less
Source PDF DOI Publisher page
75 days

FGF21 inhibits atherosclerosis by reducing endothelial ferroptosis via activation of AMPK/Nrf2 signaling

Authors
Dandan Song; Zhenzhen Chen; Chao Qi; Youyou Yan; Junnan WangShow moreShow less
Affiliations
Department of Clinical Laboratory, Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun 130041, China; Department of Cardiology, Second Hospital of Jilin University, Changchun, Jilin 130041, China; Changbaishan Laboratory, Jilin University, Changchun 130012, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does International Immunopharmacology take to review a manuscript?

As of 2026-11-13, CrushSCI has 15 complete review records for International Immunopharmacology. The fastest paper went from submission to acceptance in 24 days (Targeted co-delivery of SPAG5 siRNA and a PD-L1 inhibitor using nanoliposomes enhances antitumor immunity in a murine prostate cancer model, received 2026-09-28, accepted 2026-10-22); the slowest took 383 days. The average is 126.1 days and the median is 106 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.